These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2128637)

  • 1. Heuristic and logistic principles of ST-segment interpretation in the time domain. Evolution in the context of the TAMI 7 trial design.
    Krucoff MW; Croll MA; Pope JE; Granger CB; Pieper KS; Sigmon KN; Lee KL; Califf RM
    J Electrocardiol; 1990; 23 Suppl():6-10. PubMed ID: 2128637
    [No Abstract]   [Full Text] [Related]  

  • 2. The thrombolysis and angioplasty in myocardial infarction (TAMI) trial: review and nursing implications.
    Pitts P; Fenwick B; Fromberg B
    Prog Cardiovasc Nurs; 1990; 5(2):65-72. PubMed ID: 2116622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precordial ST segment depression predicts a worse prognosis in inferior infarction despite reperfusion therapy. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.
    Bates ER; Clemmensen PM; Califf RM; Gorman LE; Aronson LG; George BS; Kereiakes DJ; Topol EJ
    J Am Coll Cardiol; 1990 Dec; 16(7):1538-44. PubMed ID: 2123903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations.
    Krucoff MW; Green CL; Langer A; Klootwijk LJ; Trollinger KM; Sawchak ST; Wilderman NM; Veldkamp RF; Pope JE; Simoons ML
    J Electrocardiol; 1993; 26 Suppl():249-55. PubMed ID: 8189133
    [No Abstract]   [Full Text] [Related]  

  • 5. Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Langer A; Krucoff MW; Klootwijk P; Veldkamp R; Simoons ML; Granger C; Califf RM; Armstrong PW
    J Am Coll Cardiol; 1995 Jun; 25(7):1552-7. PubMed ID: 7759706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group.
    Langer A; Minkowitz J; Dorian P; Casella L; Harris L; Morgan CD; Armstrong PW
    J Am Coll Cardiol; 1992 Nov; 20(6):1313-7. PubMed ID: 1430680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST segment tracking for rapid determination of patency of the infarct-related artery in acute myocardial infarction.
    Fernandez AR; Sequeira RF; Chakko S; Correa LF; de Marchena EJ; Chahine RA; Franceour DA; Myerburg RJ
    J Am Coll Cardiol; 1995 Sep; 26(3):675-83. PubMed ID: 7642858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy.
    Steinberg JS; Hochman JS; Morgan CD; Dorian P; Naylor CD; Theroux P; Topol EJ; Armstrong PW
    Circulation; 1994 Aug; 90(2):746-52. PubMed ID: 8044943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconsidering arrhythmias as markers of reperfusion. Combined arrhythmia and ST-segment analysis during myocardial infarction.
    Gressin V; Gorgels A; Louvard Y; Maison-Blanche P
    J Electrocardiol; 1993; 26 Suppl():262-9. PubMed ID: 8189136
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction. Tissue Plasminogen Activator: Toronto (TPAT) Study Group.
    Dorian P; Langer A; Morgan C; Casella L; Harris L; Armstrong P
    Am J Cardiol; 1994 Sep; 74(5):419-23. PubMed ID: 7520209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators).
    Langer A; Goodman SG; Topol EJ; Charlesworth A; Skene AM; Wilcox RG; Armstrong PW
    J Am Coll Cardiol; 1996 May; 27(6):1327-32. PubMed ID: 8626939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarction.
    Baskin JM; Wilkins ML; Ohman EM; Clemmensen P; Grande P; Christenson RH; Sevilla DC; Wagner NB; Wagner GS
    Am J Cardiol; 1993 Jun; 71(15):1362-5. PubMed ID: 8498383
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous ST segment recording during thrombolysis in acute myocardial infarction: a report on orthogonal ECG monitoring.
    Badir BF; Nasmith JB; Dutoy JL; Dubé B; Cardinal R; LeBlanc AR; Nadeau R
    Can J Cardiol; 1995; 11(7):545-52. PubMed ID: 7656190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.
    Granger CB; Califf RM; Young S; Candela R; Samaha J; Worley S; Kereiakes DJ; Topol EJ
    J Am Coll Cardiol; 1993 Mar; 21(4):920-5. PubMed ID: 8450161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated ST-segment reduction after thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) compared to urokinase.
    Derad I; Stierle U; Giannitsis E; Potratz J; Born J; Djonlagic H; Fehm HL
    Jpn Heart J; 1996 Jan; 37(1):33-41. PubMed ID: 8632624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.
    Singh N; Mironov D; Armstrong PW; Ross AM; Langer A
    Circulation; 1996 Apr; 93(7):1388-95. PubMed ID: 8641028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.
    Langer A; Krucoff MW; Klootwijk P; Simoons ML; Granger CB; Barr A; Califf RM; Armstrong PW
    J Am Coll Cardiol; 1998 Mar; 31(4):783-9. PubMed ID: 9525547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reperfusion strategy for simultaneous ST-segment elevation myocardial infarction and acute ischemic stroke within a time window.
    González-Pacheco H; Méndez-Domínguez A; Vieyra-Herrera G; Azar-Manzur F; Meave-González A; Rodríguez-Zanella H; Martínez-Sánchez C
    Am J Emerg Med; 2014 Sep; 32(9):1157.e1-4. PubMed ID: 24703066
    [No Abstract]   [Full Text] [Related]  

  • 19. Dynamic QRS-complex and ST-segment monitoring in acute myocardial infarction during recombinant tissue-type plasminogen activator therapy. The TEAHAT Study Group.
    Dellborg M; Riha M; Swedberg K
    Am J Cardiol; 1991 Feb; 67(5):343-9. PubMed ID: 1899776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitated PCI for ST segment elevation myocardial infarction.
    Young JJ
    J Invasive Cardiol; 2004 Sep; Suppl():4-9. PubMed ID: 23573663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.